A detailed history of Israel Englander (Millennium Management LLC) transactions in Passage Bio, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 163,859 shares of PASG stock, worth $106,508. This represents 0.0% of its overall portfolio holdings.

Number of Shares
163,859
Previous 750,926 78.18%
Holding current value
$106,508
Previous $593,000 80.78%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$0.64 - $1.0 $375,722 - $587,067
-587,067 Reduced 78.18%
163,859 $114,000
Q2 2024

Aug 14, 2024

SELL
$0.79 - $1.58 $90,702 - $181,404
-114,813 Reduced 13.26%
750,926 $593,000
Q1 2024

May 15, 2024

BUY
$0.86 - $1.73 $66,705 - $134,185
77,564 Added 9.84%
865,739 $1.17 Million
Q4 2023

Feb 14, 2024

BUY
$0.6 - $1.01 $348,427 - $586,519
580,712 Added 279.91%
788,175 $796,000
Q2 2023

Aug 14, 2023

SELL
$0.82 - $1.19 $74,314 - $107,846
-90,627 Reduced 30.4%
207,463 $195,000
Q1 2023

May 15, 2023

SELL
$0.96 - $1.88 $183,754 - $359,852
-191,411 Reduced 39.1%
298,090 $285,000
Q4 2022

Feb 14, 2023

SELL
$1.06 - $1.48 $86,645 - $120,976
-81,741 Reduced 14.31%
489,501 $676,000
Q3 2022

Nov 14, 2022

BUY
$1.22 - $2.48 $235,323 - $478,362
192,888 Added 50.98%
571,242 $714,000
Q2 2022

Aug 15, 2022

BUY
$1.63 - $3.46 $340,404 - $722,576
208,837 Added 123.2%
378,354 $893,000
Q1 2022

May 16, 2022

SELL
$2.66 - $6.49 $93,464 - $228,039
-35,137 Reduced 17.17%
169,517 $526,000
Q4 2021

Feb 14, 2022

SELL
$6.24 - $10.2 $870,629 - $1.42 Million
-139,524 Reduced 40.54%
204,654 $1.3 Million
Q3 2021

Nov 15, 2021

BUY
$9.73 - $15.52 $1.45 Million - $2.31 Million
148,982 Added 76.32%
344,178 $3.43 Million
Q2 2021

Aug 16, 2021

BUY
$12.44 - $19.45 $2.43 Million - $3.8 Million
195,196 New
195,196 $2.58 Million
Q1 2021

May 17, 2021

SELL
$16.24 - $29.83 $1.75 Million - $3.21 Million
-107,579 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$14.28 - $29.73 $720,997 - $1.5 Million
50,490 Added 88.44%
107,579 $2.75 Million
Q3 2020

Nov 16, 2020

BUY
$12.39 - $26.15 $707,332 - $1.49 Million
57,089 New
57,089 $748,000
Q2 2020

Aug 14, 2020

SELL
$14.59 - $36.07 $2.39 Million - $5.91 Million
-163,853 Closed
0 $0
Q1 2020

May 14, 2020

BUY
$8.86 - $22.2 $1.45 Million - $3.64 Million
163,853 New
163,853 $2.58 Million

Others Institutions Holding PASG

About Passage BIO, Inc.


  • Ticker PASG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,463,200
  • Market Cap $35.4M
  • Description
  • Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 ...
More about PASG
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.